Switzerland
New Akina co-investment fund reaches €50m first close
Akina usually invests €2-15m in companies valued between €25-500m
MS Ventures backs Inthera Bioscience’s €3.4m round
MS Ventures is the corporate venture capital fund of healthcare business Merck
DBAG buys minority stake in Mageba
DBAG scores its first ever Swiss deal, also plans capital increase for the company
Chequers buys Spandex from Gilde
Gilde scores 3x money on the sale of the Swiss sign-making and printing business
Z Capital buys Swiss hotel Waldhaus Flims
Hotel went into administration earlier this year
Challenging 2015 for Switzerland and Austria
A look back over 2015 activity in the DACH region
Waterland exits FleetPro to management
GP acquired River Advice in 2010 and supported the acquisition of International Shipping Partners in 2012
Invision closes sixth fund on CHF 350m
GP has invested CHF 500m in equity since it launched
SHS acquires SIS-Schwager Group
GP closed fourth fund on €125m in May
VC-backed Kuros merges with listed Cytos
Kuros recently raised CHF 20m
Akina holds third close for Euro Choice VI at €180m
Vehicle aiming for €300m final close in 2016
HBM backs Obseva’s CHF 60m series-B
Company develops drugs for reproductive health
Invision acquires majority stake in Schneider Group
Deal marks Invision's first investment for 2015
LifeCare-backed Kuros raises CHF 5m extension
Company has been developing biomaterials since 2000
BlackFin buys New Access Banking Software
Company was founded in 2000
EQT's Sportradar scores $44m funding round
Existing investor EQT stays on board, Michael Jordan joins
Sequana Medical raises CHF 9m series-C extension
New investors Salus Partners and Quest for Growth provide CHF 3.7m
Redalpine scores 10x exit from InSphero
Asset sold to family office
KKR buys Selecta from ACP
GP held minority stake since 2014
Sofinnova backs Asceneuron’s CHF 30m series-A
Company is a spin-off from Merck Serono
Mountain Cleantech backs Pessl Instruments
VC injects between €1-5m
SHS and BWK buy minority stake in NDD Medizintechnik
Company operates in Europe, the US and Asia
Montana’s third secondary fund closes on €400m hard-cap
Fund has attracted 15 investors
Auven’s ADC Therapeutics raises $80m
Company is active in Europe and the US